Proposed Data Collections Submitted for Public Comment and Recommendations, 77758-77759 [E6-22118]
Download as PDF
77758
Federal Register / Vol. 71, No. 248 / Wednesday, December 27, 2006 / Notices
be submitted by e-mail to
OCAS@CDC.GOV.
be submitted by e-mail to
OCAS@CDC.GOV.
be submitted by e-mail to
OCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 06–9876 Filed 12–26–06; 8:45 am]
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 06–9877 Filed 12–26–06; 8:45 am]
John Howard, M.D.
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 06–9875 Filed 12–26–06; 8:45 am]
BILLING CODE 4163–19–M
BILLING CODE 4163–19–M
BILLING CODE 4163–19–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for Occupational
Safety and Health; Final Effect of
Designation of a Class of Employees
for Addition to the special Exposure
Cohort
National Institute for Occupational
Safety and Health; Final Effect of
Designation of a Class of Employees
for Addition to the special Exposure
Cohort
Centers for Disease Control and
Prevention
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
AGENCY:
ACTION:
Notice.
The Department of Health and
Human Services (HHS) gives notice
concerning the final effect of the HHS
decision to designate a class of
employees at the Oak Ridge Thermal
Diffusion Plant (S–50), Oak Ridge,
Tennessee, as an addition to the Special
Exposure Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000. On
November 9, 2006, as provided for
under 42 U.S.C. 7384q(b), the Secretary
of HHS designated the following class of
employees as an addition to the SEC:
SUMMARY:
SUMMARY: The Department of Health and
Human Services (HHS) gives notice
concerning the final effect of the HHS
decision to designate a class of
employees at the Oak Ridge Institute of
Nuclear Studies Cancer Research
Hospital, Oak Ridge, Tennessee, as an
addition to the Special Exposure Cohort
(SEC) under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. On November 9,
2006, as provided for under 42 U.S.C.
7384q(b), the Secretary of HHS
designated the following class of
employees as an addition to the SEC:
Employees of the Department of Energy
predecessor agencies and their contractors or
subcontractors who were monitored or
should have been monitored while working
at S–50 Oak Ridge Thermal Diffusion Plant
(S–50) for a number of work days aggregating
at least 250 work days during the period from
july 9, 1944 through December 31, 1951, or
in combination with work days within the
parameters established for one or more other
classes of employees in the SEC.
Employees of the Department of Energy
predecessor agencies and their contractors or
subcontractors who were monitored or
should have been monitored while working
at the Oak Ridge Institute of Nuclear Studies
Cancer Research Hospital from May 15, 1950,
through December 31, 1963, and who were
employed for a number of work days
aggregating at least 250 work days or in
combination with work days within the
parameters established for one or more other
classes of employees in the SEC.
This designation became effective on
December 9, 2006, as provided for under
42 U.S.C. 73841(14)(C). Hence,
beginning on December 9, 2006,
members of this class of employees,
defined as reported in this notice,
became members of the Special
Exposure Cohort.
This designation became effective on
December 9, 2006, as provided for under
42 U.s.C. 73841(14)(C). Hence,
beginning on December 9, 2006,
members of this class of employees,
defined as reported in this notice,
became members of the Special
Exposure Cohort.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
jlentini on PROD1PC65 with NOTICES
FOR FURTHER INFORMATION CONTACT:
Larry Elliottt, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
VerDate Aug<31>2005
20:43 Dec 26, 2006
Jkt 211001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
[60Day-07–04JL]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Intervention Development to Increase
Cervical Cancer Screening Among
Mexican American Women: Phase 2—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Differences in incidence of invasive
cervical cancer exist among some
minority populations. Among women
E:\FR\FM\27DEN1.SGM
27DEN1
Federal Register / Vol. 71, No. 248 / Wednesday, December 27, 2006 / Notices
older than age 29, cervical cancer
incidence for Hispanic women was
approximately twice that for nonHispanic women. Papanicolaou (Pap)
tests can prevent cervical cancer.
Nevertheless, recent studies suggest that
Hispanic women in the United States
and Puerto Rico under-use cervical
cancer screening tests. Additionally,
survey data have shown that Hispanic
women in the international border
region of the United States under-utilize
these Pap tests compared to nonHispanic women in the same region.
The need exists to increase Pap test
screening among Hispanic women
living in the United States.
The purpose of this project is to refine
a multi-component behavioral
intervention delivered by lay health
workers to increase cervical cancer
screening among U.S. and foreign-born
Mexican women. The proposed study
will use personal interviews and
workshops. There will be no cost to
respondents other than their time.
Estimated Annualized Burden Hours
Type of data collection
Number of
respondents
Number of
responses
per respondent
Average
burden per
responses
(in hours)
Personal interviews ..........................................................................................................
Workshops .......................................................................................................................
Total ..........................................................................................................................
128
60
....................
1
1
....................
2
5.5
....................
Dated: December 14, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–22118 Filed 12–26–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–091]
NIOSH Proposed Revision of the
‘‘Occupational Exposure Sampling
Strategies Manual (OESSM)’’
The National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
ACTION: Notice to request public
comments.
AGENCY:
jlentini on PROD1PC65 with NOTICES
77759
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) is considering updating the
Occupational Exposure Sampling
Strategies Manual(OESSM), NIOSH
Document Number: DHHS (NIOSH)
Publication Number 77–173; and
requests user feedback to maximize the
relevancy of any revisions to the
document. Specifically, NIOSH seeks
input in the following areas:
1. The relevance, currency, and
appropriateness of the OESSM;
identification of the most useful
components of the OESSM; information
on the disciplines and jobs of current
users; and other useful resources related
to sampling strategies.
2. The need for an updated/revised
OESSM; the types of information
needed but not currently included in
the OESSM; the revisions needed to
make the OESSM more useful; the gaps,
VerDate Aug<31>2005
20:43 Dec 26, 2006
Jkt 211001
unmet needs for guidance, or needs for
new information; and the topics that do
not need to be updated or addressed in
the OESSM to avoid duplicating already
existing materials.
3. Information needs relative to
exposure assessment and sampling
strategies (e.g., qualitative vs.
quantitative, control banding
approaches, etc.).
4. The Action Level approach
(decision statistics, utility of the
decision logic chart in the current
OESSM [p. 11]).
5. Statistical issues, including the
need for new sampling strategy
statistics, the existing sampling strategy
applications, and the need for specific
sampling strategies that are currently
not addressed.
6. The most appropriate (needed or
preferred) dissemination medium for an
updated/revised OESSM (hard copy,
CD, Web-based, etc.), including the
preferred organizational format (e.g.,
one large document, one overview
document with several monographs on
specific topics, etc).
NIOSH expects to hold a public
meeting (date, time, and location to be
announced in the Federal Register on a
later date) for additional input on future
occupational exposure sampling
strategies guidance.
A copy of the current Occupational
Exposure Sampling Strategies Manual
and additional information related to
this announcement can be found at:
https://www.cdc.gov/niosh/review/
public/77–173.
ADDRESSES: Comments should be
submitted to the NIOSH Docket Office,
ATTN: Docket Number NIOSH–091,
Robert A. Taft Laboratories, 4676
Columbia Parkway, M/S C–34,
Cincinnati, OH 45226, telephone 513/
533–8450, fax 513/533–8285.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Total burden
(in hours)
256
165
411
Comments may also be submitted
directly through the Web site https://
www.cdc.gov/niosh/review/public/77–
173. The document will remain
available for comment until February
28, 2007.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, Room 113, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
Contact Person for Technical
Information: Mary Lynn Woebkenberg,
Ph.D., Robert A Taft Laboratories, 4676
Columbia Parkway, Mailstop C–22,
Cincinnati, Ohio 45226.
Dated: December 18, 2006.
James D. Seligman,
Chief Information Officer, Center for Disease
Control and Prevention.
[FR Doc. E6–22120 Filed 12–26–06; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Privacy Act of 1974; Report of a
Modified or Altered System of Records
Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a Modified or Altered
System of Records (SOR).
AGENCY:
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
we are proposing to modify or alter a
SOR, ‘‘CMS Fraud Investigation
Database (FID), System No. 09–70–
0527,’’ most recently modified at 67 FR
65795 (October 28, 2002). We propose to
modify existing routine use number 1
that permits disclosure to agency
E:\FR\FM\27DEN1.SGM
27DEN1
Agencies
[Federal Register Volume 71, Number 248 (Wednesday, December 27, 2006)]
[Notices]
[Pages 77758-77759]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-22118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-04JL]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Intervention Development to Increase Cervical Cancer Screening
Among Mexican American Women: Phase 2--New--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Differences in incidence of invasive cervical cancer exist among
some minority populations. Among women
[[Page 77759]]
older than age 29, cervical cancer incidence for Hispanic women was
approximately twice that for non-Hispanic women. Papanicolaou (Pap)
tests can prevent cervical cancer. Nevertheless, recent studies suggest
that Hispanic women in the United States and Puerto Rico under-use
cervical cancer screening tests. Additionally, survey data have shown
that Hispanic women in the international border region of the United
States under-utilize these Pap tests compared to non-Hispanic women in
the same region. The need exists to increase Pap test screening among
Hispanic women living in the United States.
The purpose of this project is to refine a multi-component
behavioral intervention delivered by lay health workers to increase
cervical cancer screening among U.S. and foreign-born Mexican women.
The proposed study will use personal interviews and workshops. There
will be no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average
Number of responses burden per Total
Type of data collection respondents per responses burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Personal interviews......................................... 128 1 2 256
Workshops................................................... 60 1 5.5 165
Total................................................... ........... ........... ........... 411
----------------------------------------------------------------------------------------------------------------
Dated: December 14, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-22118 Filed 12-26-06; 8:45 am]
BILLING CODE 4163-18-P